AAPL 189.07 +0.3 (+0.16%)MSFT 117.02 -0.72 (-0.62%)FB 167.35 +1.05 (+0.63%)ZNGA 5.3 -0.01 (-0.19%)NVDA 175.17 +1.31 (+0.75%)WBA 61.7 +0.14 (+0.23%)GOOG 1184.77 -8.35 (-0.70%)PIH 5.45 -0.16 (-2.85%)
AAPL 189.07 +0.3 (+0.16%)MSFT 117.02 -0.72 (-0.62%)FB 167.35 +1.05 (+0.63%)ZNGA 5.3 -0.01 (-0.19%)NVDA 175.17 +1.31 (+0.75%)WBA 61.7 +0.14 (+0.23%)GOOG 1184.77 -8.35 (-0.70%)PIH 5.45 -0.16 (-2.85%)

Financial Summary CRSP Quote CRISPR Ther

CRISPR Therapeutics AG Quote

CRISPR Therapeu (CRSP)

34.83 0.67 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C-
Symbol CRSP
Price 34.83
Beta 2.26
Vol Avg 1.15 M
Mkt cap 2.49 B
Shares 40
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -75.14% Strong Sell
ROA -49.82% Strong Sell
Operating Margin -158.54% Strong Sell
Debt/Equity 44.68% Neutral
P/E -20.49 Strong Sell
P/B 7.41 Strong Buy
Company Profile

CEO

Samarth Kulkarni

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Global Market

Description

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.